• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD ULTRA-FINE¿ INSULIN SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD ULTRA-FINE¿ INSULIN SYRINGE Back to Search Results
Catalog Number 324916
Device Problems Break (1069); Detachment of Device or Device Component (2907)
Patient Problems Pain (1994); Disability (2371); Device Embedded In Tissue or Plaque (3165)
Event Date 07/12/2015
Event Type  Injury  
Manufacturer Narrative
A sample is not available for evaluation.However, a no sample investigation will be conducted and upon completion of the investigation, a supplemental report will be submitted.
 
Event Description
It was reported that at approximately 7:00 am on (b)(6) 2015, as a consumer used a bd ultra-fine insulin syringe to inject niato medication into his penis prior to sexual intercourse, the needle broke off and remained in the corpus cavernosum of his penis.The patient went to a hospital and was hospitalized for two days.While in the hospital he received two ultrasounds to locate the broken needle and had surgery in an attempt to remove it.The surgery was unsuccessful as the needle was too deep within the consumer's penis and the doctor felt it was too risky to continue.On (b)(6) 2015 the patient had a follow up appointment with a urologist.As of the date of this report the needle remains inside the consumer's penis.The consumer also reported that he is currently unable to have sexual intercourse and that he has been treated with antibiotics (cephalexin and neomycin sulfate bacitracin) and pain medications (nimesulina and dipirone).At present, the consumer states that he is not in pain but that the incident has caused a "great nuisance.".
 
Manufacturer Narrative
Results: a sample is not available for evaluation.A review of the device history record revealed no irregularities during the manufacture of the reported lot number 5082818.Conclusion: without a sample, an absolute root cause for this incident cannot be determined.A sample is not available for evaluation.
 
Manufacturer Narrative
Correction: the date of event reported on the initial mdr was entered as (b)(6) 2015.The date of event should have been entered as (b)(6) 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ULTRA-FINE¿ INSULIN SYRINGE
Type of Device
INSULIN SYRINGE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
Manufacturer (Section G)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key5329951
MDR Text Key34483890
Report Number1920898-2015-00010
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K024112
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Patient
Type of Report Initial,Followup,Followup
Report Date 02/18/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2020
Device Catalogue Number324916
Device Lot Number5082818
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/14/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-